
DOAC Interference in Coagulation Testing: What Routine Labs Should Control
A practical routine-lab overview of DOAC interference in coagulation testing, including PT/APTT limits, special assays, heparin anti-Xa issues, and report comments.
Read updates from TY Biological about coagulation diagnostics, reagent supply, OEM cooperation and clinical laboratory needs.

A practical routine-lab overview of DOAC interference in coagulation testing, including PT/APTT limits, special assays, heparin anti-Xa issues, and report comments.

Practical guidance for coagulation reagent lot-change verification, covering patient-sample comparison, QC, calibration, acceptance criteria, documentation, and OEM support.

Practical D-Dimer reporting guidance for routine VTE workflows, covering FEU/DDU units, age-adjusted thresholds, turnaround time, QC, and reagent support.

Practical guidance on coagulation reagent stability across cold chain, open-vial life, transport exposure, QC monitoring, lot changes, and OEM launch planning.

Practical FDP reagent guidance for routine coagulation laboratories, covering analyzer application, calibration, QC, sample quality, reporting discipline, stability, and distributor support.

Practical OEM coagulation reagent guidance on fill volume, open-vial stability, bottle format, QC material, cold-chain design, and localization planning.

Practical laboratory view of the 2025 DIC scoring discussion and what D-Dimer use means for QC, reporting units, access, and reagent support.

A practical look at APTT reagent sensitivity, analyzer application, reference interval planning, lot bridging, and OEM localization support for coagulation diagnostics.

Practical guidance on Clauss fibrinogen testing, calibration curves, linearity, dilution recovery, QC trends, and analyzer application support for routine coagulation laboratories.

Thrombin time is a small assay with useful operational value when laboratories need to investigate fibrin formation, heparin effect, fibrinogen issues, or method interference.